Recognizing and managing mycobacterial diseases in clients with AIDS

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• Mycobacterial infections are prevalent in individuals with human immunodeficiency virus (HIV).
• Mycobacterium tuberculosis (MTB) causes pulmonary tuberculosis, while Mycobacterium avium intracellulare (MAI) leads to disseminated infections, particularly in advanced AIDS.
• Global incidence of pulmonary tuberculosis has risen since 1985, and MAI infections are increasingly associated with AIDS.

Purpose of the Study:

• To highlight the increasing incidence of mycobacterial diseases in HIV-infected populations.
• To differentiate the diagnostic and treatment approaches for MTB and MAI infections.
• To emphasize the importance of clinical understanding for managing these conditions in the context of rising AIDS cases.

Main Methods:

• Review of existing literature on mycobacterial infections in HIV/AIDS patients.
• Comparison of symptomatology, diagnosis, and treatment protocols for MTB and MAI.
• Analysis of disease trends and associations with AIDS progression.

Main Results:

• Pulmonary tuberculosis incidence is increasing globally.
• Disseminated MAI infections are linked to the terminal stages of AIDS.
• Treatment for pulmonary TB involves chemotherapy and isolation; MAI requires multi-drug therapy with potential side effects and does not necessitate isolation.

Conclusions:

• Clinicians must be aware of the distinct management strategies for MTB and MAI in HIV patients.
• The rising number of AIDS cases underscores the need for updated knowledge on mycobacterial disease management.
• Further research is needed for effective and tolerable treatments for disseminated MAI infections.